Clinicians should ask patients who have had an allogeneic hematopoietic stem cell transplant about their use of complementary medicines, experts advise. The call comes after Sydney haematologists found over half of allogeneic hematopoietic stem cell transplant (HSCT) survivors used at least one form of complementary and alternative therapy (CAM). The survey of 432 patients who ...
Assess complementary medicine use in HSCT survivors
By Nicola Garrett
1 Nov 2016